Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is an important cause of preventable mortality and morbidity.
A newly published paper in the Journal Thrombosis Research authored by experts Scott D. Grosse, Richard E. Nelson, Kwame A. Nyarko, Lisa C. Richardson and Gary E. Raskob, show the best currently available estimates of the aggregate economic impact of incident or prevalent VTE cases on the U.S. healthcare system range from $7 billion to $10 billion per year, consistent with the majority of previous estimates. Additionally, its estimated an incident case of VTE results in preventable medical costs of about $20,000. Additional research is needed to assess preventable costs for specific groups.
To read the paper, download here.